DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
eBay
EBAY
Collegium Pharmaceutical
COLL
Dorian LPG
LPG
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 0.665
- +0.010+1.53%
Close Mar 28 16:00 ET
- 0.780
- +0.115+17.29%
Post 20:01 ET
47.58MMarket Cap-2.06P/E (TTM)
0.695High0.610Low348.95KVolume0.695Open0.655Pre Close247.64KTurnover6.34%Turnover RatioLossP/E (Static)71.55MShares49.00052wk High1.15P/B3.66MFloat Cap0.55152wk Low--Dividend TTM5.50MShs Float49.000Historical High--Div YieldTTM12.90%Amplitude0.551Historical Low0.709Avg Price1Lot Size
About Citius Oncology Company
Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.
Company Profile
SymbolCTOR
Company NameCitius Oncology
Listing DateDec 8, 2022
Founded2021
CEOMr. Leonard L. Mazur
MarketNASDAQ
Fiscal Year Ends09-30
Address11 Commerce Drive,1st floor
CityCranford
ProvinceNew Jersey
CountryUnited States of America
Zip Code07016
Websitehttps://www.citiusonc.com
Company Executives
- Name
- Position
- Salary
- Leonard L. Mazur
- Chairman of the Board and Chief Executive Officer
- --
- Jaime Bartushak
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- --
- Dr. Myron Czuczman, M.D.
- Chief Medical Officer and President
- --
- Myron Z. Holubiak
- Director and Secretary
- --
- Carol Webb
- Independent Director
- --
- Suren G. Dutia
- Independent Director
- --
- Robert J. Smith
- Independent Director
- --
- Joel D. Mayersohn
- Independent Director
- --
- Dennis M. McGrath, C.P.A.
- Independent Director
- --
- Dr. Eugene Holuka
- Independent Director
- --